Report error Found 16 Enz. Inhib. hit(s) with all data for entry = 13337
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 0.460nMAssay Description:The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then the b...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 0.580nMAssay Description:The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then the b...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 0.700nMAssay Description:The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then the b...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 3-kinase C2 domain-containing subunit gamma(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 1.05nMAssay Description:The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then the b...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 99.1nMAssay Description:The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then the b...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 101nMAssay Description:The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then the b...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 143nMAssay Description:The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then the b...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 148nMAssay Description:The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then the b...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 170nMAssay Description:The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then the b...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 191nMAssay Description:The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then the b...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 195nMAssay Description:The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then the b...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 214nMAssay Description:The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then the b...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 237nMAssay Description:The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then the b...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 461nMAssay Description:The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then the b...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 466nMAssay Description:The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then the b...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta(Human)
HIS Pharmaceutical Co.
US Patent
HIS Pharmaceutical Co.
US Patent
Affinity DataIC50: 552nMAssay Description:The experimental procedure is briefly described as follows: the test compound was first dissolved in DMSO to prepare a stock solution, and then the b...More data for this Ligand-Target Pair
